These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33752129)

  • 1. Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development.
    Lewandowski CT; Khan MW; BenAissa M; Dubrovskyi O; Ackerman-Berrier M; LaDu MJ; Layden BT; Thatcher GRJ
    EBioMedicine; 2021 Apr; 66():103287. PubMed ID: 33752129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice.
    Almog T; Kandel Kfir M; Levkovich H; Shlomai G; Barshack I; Stienstra R; Lustig Y; Leikin Frenkel A; Harari A; Bujanover Y; Apte R; Shaish A; Harats D; Kamari Y
    BMJ Open Diabetes Res Care; 2019; 7(1):e000650. PubMed ID: 31749969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
    Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid cell-specific ABCA1 deletion does not worsen insulin resistance in HF diet-induced or genetically obese mouse models.
    Zhu X; Chung S; Bi X; Chuang CC; Brown AL; Liu M; Seo J; Cuffe H; Gebre AK; Boudyguina E; Parks JS
    J Lipid Res; 2013 Oct; 54(10):2708-17. PubMed ID: 23894207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes.
    Fan J; Zareyan S; Zhao W; Shimizu Y; Pfeifer TA; Tak JH; Isman MB; Van den Hoven B; Duggan ME; Wood MW; Wellington CL; Kulic I
    PLoS One; 2016; 11(9):e0162384. PubMed ID: 27598782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid abnormalities in alpha/beta2-syntrophin null mice are independent from ABCA1.
    Hebel T; Eisinger K; Neumeier M; Rein-Fischboeck L; Pohl R; Meier EM; Boettcher A; Froehner SC; Adams ME; Liebisch G; Krautbauer S; Buechler C
    Biochim Biophys Acta; 2015 May; 1851(5):527-36. PubMed ID: 25625330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective peroxisome proliferator-activated receptor-α modulator K-877 regulates the expression of ATP-binding cassette transporter A1 in pancreatic beta cells.
    Dong T; Lyu J; Imachi H; Kobayashi T; Fukunaga K; Sato S; Ibata T; Yoshimoto T; Yonezaki K; Iwama H; Zhang G; Murao K
    Eur J Pharmacol; 2018 Nov; 838():78-84. PubMed ID: 30201376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists.
    Nomura S; Endo-Umeda K; Makishima M; Hashimoto Y; Ishikawa M
    ChemMedChem; 2016 Oct; 11(20):2347-2360. PubMed ID: 27690261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Deletion of Adipocyte Abca1 (ATP-Binding Cassette Transporter A1) Impairs Diet-Induced Obesity.
    Cuffe H; Liu M; Key CC; Boudyguina E; Sawyer JK; Weckerle A; Bashore A; Fried SK; Chung S; Parks JS
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):733-743. PubMed ID: 29348118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary Eriodictyol Alleviates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obese Mice.
    Kwon EY; Choi MS
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Nonlipogenic ABCA1 Inducing Compounds with Potential in Alzheimer's Disease and Type 2 Diabetes.
    Ben Aissa M; Lewandowski CT; Ratia KM; Lee SH; Layden BT; LaDu MJ; Thatcher GRJ
    ACS Pharmacol Transl Sci; 2021 Feb; 4(1):143-154. PubMed ID: 33615168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressing adipocyte inflammation promotes insulin resistance in mice.
    Zhu Q; An YA; Kim M; Zhang Z; Zhao S; Zhu Y; Asterholm IW; Kusminski CM; Scherer PE
    Mol Metab; 2020 Sep; 39():101010. PubMed ID: 32408016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice.
    Shiomi Y; Yamauchi T; Iwabu M; Okada-Iwabu M; Nakayama R; Orikawa Y; Yoshioka Y; Tanaka K; Ueki K; Kadowaki T
    J Biol Chem; 2015 Jun; 290(23):14567-81. PubMed ID: 25907553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and metabolomics: metallothioneins protect against high-fat diet-induced consequences in metallothionein knockout mice.
    Lindeque JZ; Jansen van Rensburg PJ; Louw R; van der Westhuizen FH; Florit S; Ramírez L; Giralt M; Hidalgo J
    OMICS; 2015 Feb; 19(2):92-103. PubMed ID: 25683887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
    DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
    J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
    Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
    Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
    Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
    Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.
    Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
    Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
    Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.